Volume 13, Issue 6 (8-2015)                   IJRM 2015, 13(6): 373-378 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moti M, Amini L, Mirhoseini Ardakani S S, Kamalzadeh S, Masoomikarimi M, jafarisani M. Oxidative stress and anti-oxidant defense system in Iranian women with polycystic ovary syndrome. IJRM. 2015; 13 (6) :373-378
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-654-en.html
1- Department of Midwifery, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran
2- Faculty of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran
3- Department of Biology, College of Basic Sciences, Karaj Branch, Islamic Azad University, Alborz, Iran
4- Department of Immunology, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran
5- Department of Biochemistry, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran , moslem.jafarisani@gmail.com
Abstract:   (1068 Views)
Background: Polycystic ovary syndrome (PCOS) is a common disorder of infertility which affects more than 100 million women. It is characterized by chronic anovulation, hyper androgenism and obesity. PCOS is also associated with oxidative stress changes.
Objective: Here, we aimed to investigate the level of antioxidants and oxidative stress in Iranian women with PCOS as a predictive factor for cardiovascular disease for the first time in Iran.
Materials and Methods: In this cross sectional study 30 women with PCOS and 30 healthy women were included. C-reactive protein, serum insulin, advanced oxidation protein products, and level of total antioxidants status were measured from blood samples.
Results: The levels of serum insulin, C-reactive protein, advanced oxidation protein productswere significantly increased in women with PCOS compared with healthy women but there was a decrease in level of total antioxidants status in PCOS women.
Conclusion: These changes show that oxidative stress contributes to PCOS and the decrease of antioxidants leads to increase of oxidation products contributing to PCOS.
Full-Text [PDF 464 kb]   (169 Downloads) |   |   Full-Text (HTML)  (72 Views)  
Type of Study: Original Article |

References
1. Knochenhauer E, Key T, Kahsar-Miller M, Waggoner W, Boots L, Azziz R. Prevalence of the Polycystic Ovary Syndrome in unselected black and white Women of the Southeastern United States: A prospective study 1. J Clin Endocrinol Metab 1998; 83: 3078-3082. [DOI:10.1210/jc.83.9.3078]
2. Baillargeon J-P, Iuorno MJ, Nestler JE. Insulin sensitizers for polycystic ovary syndrome. Clin Obstet Gynecol 2003; 46: 325-340. [DOI:10.1097/00003081-200306000-00011]
3. Enzevaei A, Salehpour S, Tohidi M, Saharkhiz N. Subclinical hypothyroidism and insulin resistance in polycystic ovary syndrome: is there a relationship? Iran J Reprod Med 2014; 12: 481-486.
4. Akhbardeh M. Oxidative stress and antioxidant: Exposure and impact on female fertility. Iran J Reprod Med 2009; 7 (Suppl.): 1.
5. Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 1997; 126: 32-35. [DOI:10.7326/0003-4819-126-1-199701010-00005]
6. Slowińska-Srzednicka J, Zgliczyński S, Wierzbicki M, Srzednicki M, Stopińska-Gluszak U, Zgliczyński W, et al. The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest 1991; 14: 569-575. [DOI:10.1007/BF03346870]
7. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405-412. [DOI:10.2337/diab.40.4.405]
8. Riemersma R, Wood D, Oliver M, Elton R, Macintyre C, Gey K. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991; 337: 1-5. [DOI:10.1016/0140-6736(91)93327-6]
9. Liu SX, Hou FF, Guo ZJ, Nagai R, Zhang WR, Liu ZQ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol 2006; 26: 1156-1162. [DOI:10.1161/01.ATV.0000214960.85469.68]
10. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995; 274: 1049-1057. [DOI:10.1001/jama.1995.03530130055028]
11. Ferriman D, Gallwey J. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447. [DOI:10.1210/jcem-21-11-1440]
12. Gu HF, Efendic S, Nordman S, Östenson CG, Brismar K, Brookes AJ, et al. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. Diabetes 2004; 53: 2137-2142. [DOI:10.2337/diabetes.53.8.2137]
13. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996; 49: 1304-1313. [DOI:10.1038/ki.1996.186]
14. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721-724. [DOI:10.1016/S0140-6736(94)92211-X]
15. Sohal R. The free radical hypothesis of aging: an appraisal of the current status. Aging 1993; 5: 3-17. [DOI:10.1007/BF03324120]
16. Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996; 273: 59-63. [DOI:10.1126/science.273.5271.59]
17. Garibaldi S, Valentini S, Aragno I, Pronzato MA, Traverso N, Odetti P. Plasma protein oxidation and antioxidant defense during aging. Int J Vitamin Nutr Res 2001; 71: 332-338. [DOI:10.1024/0300-9831.71.6.332]
18. Riemersma RA, Wood DA, Macintyre CC, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, Cand E and carotene. Lancet 1991; 337: 1-5. [DOI:10.1016/0140-6736(91)93327-6]
19. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. VitaminE consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-1449. [DOI:10.1056/NEJM199305203282003]
20. Brousseau ME, Schaefer EJ. New targets for medical treatment of lipid disorders. Curr Atheroscler Rep 2002; 4: 343-349. [DOI:10.1007/s11883-002-0071-x]

Send email to the article author


© 2021 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb